asthma
copd
ard
inflammatori
diseas
upregul
cytokin
chemokin
protein
lead
recruit
influx
inflammatori
cell
mitogen
activ
protein
kinas
mapk
play
key
role
process
via
ligand
bind
receptor
cellular
stress
box
small
gprotein
activ
mapk
kinas
kinas
phosphoryl
activ
mapk
kinas
mkk
fig
activ
four
b
g
wherea
activ
b
mapk
isoform
downstream
target
numer
play
role
regul
inflamm
via
transcript
posttranscript
translat
target
fig
final
understand
mapk
biolog
import
appreci
commonli
avail
inhibitor
select
current
knowledg
target
fig
respons
tabl
reflect
activ
map
kinas
cellular
stress
inflammatori
cytokin
tnfa
well
establish
fig
addit
newer
stimuli
exampl
proinflammatori
cytokin
induc
synthesi
see
prime
neutrophil
function
novel
cytokin
upregul
cytokin
chemokin
express
eosinophil
continu
describ
box
howev
virus
bacteria
caus
agent
pulmonari
diseas
along
product
also
activ
mapk
increasingli
come
light
princip
caus
exacerb
asthma
copd
thu
respiratori
viral
infect
exampl
human
rhinoviru
hrv
respiratori
syncyti
viru
rsv
upregul
express
multipl
cytokin
tnfa
gcsf
gmcsf
chemokin
groa
rant
epitheli
cell
well
endotheli
cell
via
mapk
pathway
activ
mapk
influenza
viru
iv
includ
bird
flu
strain
suggest
similar
induct
cytokin
chemokin
effect
like
mediat
via
apoptosi
signalregul
kinas
ask
also
respons
ivinduc
apoptot
cell
death
furthermor
find
doubl
strand
rna
dsrna
act
via
dsrnadepend
protein
kinas
pkr
mimic
respons
mani
rna
virus
includ
rsv
hrv
iv
suggest
gener
respons
viral
infect
addit
hrv
infect
alveolar
macrophag
monocyt
cell
lead
activ
transcript
factor
atf
phosphory
well
induct
express
therefor
despit
affect
hrv
replic
iv
infect
iv
sever
acut
respiratori
syndrom
sar
viral
protein
synthesi
data
indic
therapeut
potenti
target
mapk
epitheli
macrophag
cell
context
virusinduc
inflamm
apoptosi
similarli
bacteri
product
lipopolysaccharid
lp
potent
induc
mapk
lpsinduc
ard
pathway
play
role
bronchoconstrict
neutrophil
recruit
numer
bacteri
pathogen
also
induc
pulmonari
inflammatori
respons
via
mapk
exampl
burkholderia
pseudomallei
caus
agent
melioidosi
activ
mapk
appear
necessari
epitheli
cell
invas
burkholderia
cenocepacia
pathogen
caus
fatal
pulmonari
diseas
immunocompromis
cf
suffer
induc
express
bradykinin
kinnin
receptor
presum
inflammatori
mediat
via
mechan
fibroblast
likewis
streptococcu
pneumonia
predomin
caus
communityacquir
pneumonia
major
caus
death
infecti
diseas
industrialis
countri
induc
express
via
pathway
also
true
cell
fraction
lipopeptid
nontyp
haemophilu
influenza
major
caus
copd
exacerb
addit
sever
novel
inflammatori
compound
includ
pollut
ultrafin
carbon
partic
cigarett
smoke
lipid
mediat
leukotrien
c
ltc
ltd
well
mechan
stretch
cholinerg
stimul
activ
mapk
might
therefor
contribut
inflammatori
process
interestingli
respons
cigarett
smoke
synergist
increas
heatinactiv
bacteria
suggest
possibl
combinatori
effect
diseas
copd
mapk
regul
gene
transcript
via
phosphoryl
numer
transcript
factor
fig
addit
activ
major
posit
regul
inflammatori
gene
also
enhanc
increas
express
constitu
protein
cjun
cfo
case
phosphoryl
tenari
complex
factor
tcf
promot
interact
serum
respons
factor
srf
drive
transcript
serum
respons
element
sre
found
cfo
promot
altern
effect
mediat
via
adenosineand
uridin
au
rich
element
untransl
region
utr
cfo
cjun
also
enhanc
express
see
mapk
also
act
downstream
transcript
factor
dna
bind
thu
mapk
potenti
transcript
compet
dna
bind
inflammatori
transcript
factor
nfkb
via
process
may
also
determin
differenti
respons
nfkbdepend
gene
similarli
inhibitor
prevent
pneumoniaedepend
induct
gmcsf
bronchial
epitheli
cell
block
nfkbdepend
transcript
phosphoryl
nuclear
transcloc
recruit
promot
glucocorticosteroid
control
asthma
occur
via
glucocorticoid
receptor
gr
howev
patient
clinic
util
limit
steroidinsensit
phenomenon
may
involv
phosphoryl
gr
mapk
reduc
antiinflammatori
abil
see
certainli
phosphoryl
gr
diminish
grdepend
transcript
respons
given
role
steroidinduc
growth
factor
egf
pgdf
tgfb
neurotransmitt
kinin
other
substanc
p
bradykinin
acetylcholin
methacholin
adenosin
fmlp
platelet
activ
factor
paf
leukotrien
ltc
ltd
oxid
stress
ro
stretch
hyperosmolar
hypoxia
bacteri
product
lp
peptidoglycan
burkholderia
pseudomallei
burkholderia
cenocepacia
haemophilu
influenza
pseudomona
aeruginosa
streptococcu
pneumonia
influenza
viru
iv
respiratroy
synccyti
viru
rsv
adenoviru
human
rhinoviru
hrv
sar
viru
diesel
exhaustcarbon
particul
cigarett
smoke
co
carbonmonoxid
thrombin
ecm
compon
ligat
igefceri
ligat
ligat
serum
phorbol
ester
dsrna
mapk
activ
stimuli
list
taken
current
review
refer
present
list
therefor
exhaust
gene
antiinflammatori
action
glucocorticosteroid
point
involv
steroid
resist
characteris
cytokinesuppress
antiinflammatori
drug
csaid
inhibitor
reveal
inhibit
cytokin
biosynthesi
via
posttranscript
translat
mechan
involv
downstream
kinas
mapk
activ
protein
kinas
particularli
relev
gene
tnfa
contain
are
utr
tabl
inde
mani
inflammatori
gene
contain
one
tabl
mrna
stabilis
therefor
regul
inflammatori
viral
induc
gene
express
despit
identif
numer
arebind
protein
arebp
fig
consider
uncertainti
target
pathway
said
bind
heterogen
nuclear
ribonuclear
protein
hnrnp
tnfa
utr
block
inhibitor
correl
mrna
stabil
similarli
bind
hnrnp
tnfa
increas
follow
phosphoryl
mnk
kinas
also
implic
translat
via
phosphoryl
eukaryot
initi
factor
see
fig
furthermor
mnk
knockdown
pharmacolog
inhibit
reduc
tnfa
express
support
role
pathway
complex
introduc
stabilis
certain
arecontain
mrna
eg
tnfa
occur
via
block
deadenyl
promot
mrna
stabil
translat
coupl
polya
tail
length
fig
thu
polya
tail
shorten
reduc
translat
effici
preced
mrna
degrad
target
mapk
regul
inflammatori
gene
express
fig
mapk
subject
inhibit
three
main
class
phosphatas
context
dualspecif
phosphatas
mapk
phosphatas
rapidli
induc
proinflammatori
stimuli
exampl
lp
alveolar
macrophag
termin
signal
also
induc
glucocorticosteroid
illustr
antiinflammatori
mechan
steroiddepend
transcript
prevent
biosynthesi
transcript
posttranscript
translat
fig
inflammatori
mediat
furthermor
campelev
agent
also
induc
rais
possibl
role
antiinflammatori
effect
long
act
b
agonist
campelev
drug
one
surpris
consequ
reduc
activ
induct
tolllik
nontyp
h
influenza
nthi
subject
feedback
inhibit
nthi
infect
presenc
glucocorticosteroid
enhanc
express
signal
increas
releas
cytokin
chemokin
thu
induc
inhibit
glucocorticoid
enhanc
inflammatori
respons
certain
infect
could
also
occur
context
inhibitor
note
bind
arebp
utr
impart
consider
regulatori
control
tristetraprolin
ttp
one
protein
respons
mrna
destabilis
delet
elev
tnfa
express
lead
variou
inflammatori
disord
acut
phase
gene
induc
proinflammatori
stimuli
provid
negativefeedback
control
therefor
inhibit
proinflammatori
pathway
could
prevent
ttp
express
stabilis
enhanc
express
contain
gene
context
pathway
act
via
ttp
stabilis
ttp
mrna
inhibit
profoundli
reduc
ttp
express
furthermor
ttp
destabilis
activ
might
requir
phosphoryl
provid
addit
evid
effect
mapk
ttp
might
desir
inflamm
key
modulatori
role
includ
express
antiinflammatori
cytokin
induct
suppressor
cytokin
signal
mapk
target
arebp
hnrnp
via
mnk
respect
may
play
role
mrna
stabilis
protein
may
target
mapk
includ
pabp
arebp
addit
mapk
may
also
target
deadenylas
prevent
loss
polya
tail
promot
mrna
stabil
translat
along
phosphoryl
may
facilit
associ
polya
cap
structur
event
could
promot
arebp
lead
enhanc
effici
translat
final
mapk
act
via
promot
ttp
express
also
activ
ttp
phosphoryl
exert
neg
feedback
control
destabilis
contain
mrna
abbrevi
auf
aubind
factor
butyraterespons
factor
hn
rnp
heterogen
nuclear
ribonuclear
protein
cellrestrict
intracellular
tiar
tiarel
protein
ling
might
import
diseas
asthma
limit
signal
via
cytokin
receptor
inhibit
mapk
could
lead
exagger
respons
amplif
diseas
mani
respons
exampl
releas
respons
suggest
major
effect
neutrophil
diseas
neutrophil
influx
usual
hallmark
oblit
bronchiol
follow
lung
transplant
use
vivo
rat
model
inhibitor
shown
dramat
reduc
inflammatori
cytokin
tracheal
occlus
organ
reject
consist
data
lpschalleng
mice
tnfa
product
reduc
potent
secondgener
inhibitor
see
ref
therein
likewis
ovalbumin
ova
sensitis
challeng
mous
model
inhibitor
prevent
neutrophil
increas
bronchoalveolar
lavag
bal
fluid
interestingli
whilst
increas
cytokin
level
interferong
goblet
cell
hyperplasia
unaffect
mice
treat
inhibitor
reveal
significantli
decreas
airway
hyperreact
ahr
similarli
ovainduc
eosinophil
inflamm
mice
guinea
pig
also
prevent
see
compound
reduc
ltd
eosinophilia
promot
eosinophil
apoptosi
suggest
benefici
effect
eosinophil
diseas
asthma
conclus
also
receiv
support
ovainduc
mous
asthma
model
antisens
oligonucleotid
mapk
prevent
pulmonari
eosinophilia
ahr
mucu
hypersecret
addit
lung
oedema
frequent
associ
diseas
promot
downregul
epitheli
sodium
channel
enaca
reduc
water
ion
transport
tissu
process
requir
mapk
inhibitor
could
aid
control
lung
oedema
term
infect
diseas
exacerb
epitheli
cell
copd
patient
show
enhanc
well
addit
versu
noncopd
patient
mapkdepend
inflammatori
respons
h
influenza
likewis
cf
tissu
show
enhanc
respons
pseudomona
aeruginosa
lp
via
increas
releas
neutrophil
migrat
therefor
suggest
benefit
inhibit
cf
inflamm
one
possibl
worri
respect
inhibit
infect
relat
abil
dna
contain
unmethyl
cpg
occur
context
bacteri
infect
induc
strong
immun
respons
reduc
develop
allerg
asthma
mous
model
effect
might
part
immunolog
educ
requir
releas
cytokin
alveolar
macrophag
thu
use
inhibitor
combat
inflamm
infect
could
subsequ
enhanc
develop
allerg
diseas
anoth
frequent
fatal
diseas
rel
rapid
onset
idiopath
pulmonari
fibrosi
ipf
poorli
respons
current
treatment
characteris
irrevers
lung
fibrosi
report
involv
mapk
given
role
mapk
express
growth
factor
fibroblast
function
possibl
inhibit
may
prove
therapeut
benefit
exampl
reveal
critic
role
mapk
regul
inflammatori
gene
express
suggest
key
role
pulmonari
diseas
effect
occur
variou
transcript
posttranscript
translat
mechan
data
present
support
potenti
use
inhibitor
control
inflammatori
respons
fact
antiinflammatori
glucocorticoid
target
pathway
via
induct
support
pharmacolog
rational
target
mapk
inflamm
furthermor
find
mapk
target
gr
reduc
respons
rais
possibl
inhibitor
could
use
right
antiinflammatori
agent
also
conjunct
glucocorticosteroid
improv
patient
sensit
compound
effect
could
particularli
valuabl
context
steroid
resist
insensit
patient
often
remain
poorli
control
requir
high
dose
oral
corticosteroid
context
diseas
progress
copd
poorli
respons
glucoccorticosteroid
pathogenesi
involv
neutrophil
inhibitor
appear
effect
target
neutrophil
function
mani
copd
trigger
exampl
cigarett
smoke
particul
promot
neutrophil
recruit
via
pathway
inhibitor
pathway
may
show
benefit
diseas
addit
viral
bacteri
inflect
potent
induc
mapk
lead
signific
health
issu
aris
directli
infecti
diseas
well
exacerb
condit
asthma
copd
thu
situat
underli
infect
control
mean
antibiot
antivir
possibl
inhibit
may
appropri
deal
sole
result
inflammatori
respons
notwithstand
posit
outlook
note
process
also
take
signific
role
feedback
inhibit
inflammatori
gene
via
express
activ
ttp
remov
control
process
could
tend
increas
inflammatori
gene
express
thu
balanc
posit
neg
effect
stimulusand
genespecif
becom
appar
follow
studi
addit
whilst
evid
infect
exampl
b
pseudomallei
might
requir
mapk
less
certain
respect
infecti
agent
issu
still
requir
specif
test
furthermor
find
express
signal
enhanc
inhibit
result
loss
feedback
control
rais
possibl
inhibitor
effect
context
certain
infect
final
loss
express
could
lead
enhanc
inflammatori
respons
time
lead
develop
elev
allerg
reaction
conclus
data
indic
clear
abil
inhibitor
target
inflamm
certain
question
remain
potenti
undesir
event
could
limit
clinic
util
compound
